In May 2025, Sichuan Xieli Pharmaceutical Co., Ltd. made a remarkable appearance at the Vitafoods Europe exhibition held in Barcelona, Spain. As a leading global event for nutritional health products and functional food ingredients, the exhibition brought together industry leaders, experts, scholars, and professional buyers from around the world.
At the exhibition, Sichuan Xieli Pharmaceutical was represented by its Business Director and foreign trade team, highlighting the company’s core plant extract and natural active ingredient products, including Berberine HCl, Hesperidin, Rutin, Ursodeoxycholic Acid, Curcumin, and other key products.
As a well-known domestic manufacturer of APIs and natural plant extracts, Xieli Pharm participated in the exhibition to further expand the global influence of its plant extract products, particularly in the European market. During the event, the team held in-depth discussions with clients from Europe, the America, Southeast Asia, the Middle East, and other regions, detailing the company’s strengths in quality control, production capabilities, and international certifications, which garnered widespread attention and high praise.
"The growing global demand for natural and healthy ingredients has created significant opportunities," said the Business Director. "We aim to leverage the international platform of Vitafoods to enable more partners to recognize Xieli’s technical expertise and product value, and to promote Chinese plant extract brands on the global stage."
The ongoing technological revolution is rapidly reshaping the global health industry. Driven by the integration of artificial intelligence, biotechnology, intelligent manufacturing, and other advanced technologies, the entire industry chain, from raw material R&D and production management to warehousing logistics, quality tracking, cross-border trade, and terminal sales, is undergoing technology-driven upgrading and reconstruction. In particular, in the fields of dietary supplements and plant extracts, green, safe, efficient, and traceable characteristics have become new benchmarks in the international market, placing higher demands on enterprises’ technological accumulation and global adaptability.
In response to this trend, Xieli Pharmaceutical adheres to a dual-drive strategy of "Technology + Internationalization," proactively embracing opportunities brought by global industrial chain restructuring. The company continues to strengthen product R&D and quality standards, actively promoting its products to meet market access requirements in Europe and the United States. Meanwhile, through exhibitions, sales channels, and overseas partnerships, it continuously expands its international market presence. Xieli’s products are increasingly gaining wide recognition from global customers.
Committing to the international development path is not only a strategic choice to adapt to industry changes but also a crucial step in elevating Chinese health ingredient brands to high-end global markets. Xieli Pharmaceutical will continue to base itself in China while embracing the world, using professionalism and innovation as bridges to unlock greater value for Chinese natural health ingredients in the global market.
